| Catalog No. | Product Name | Specification |
| CRB00-1011 | ResiQuant® Mycoplasma Detection Kit (Taqman) | 50T |
| CRB00-1012 | ResiQuant® Mycoplasma Detection Kit (Taqman) | 100T |
Product Overview
Mycoplasma contamination is common in most cell culture and tissue culture laboratories. In biological drug safety control, most of pharmacopeias, including EP, USP, and JP, recommend using nucleic acid amplification testing (NAT) as a complementary or alternative method for mycoplasma release test. ResiQuant® Mycoplasma Detection Kit (Taqman) targeting the highly conserved gene fragment of mycoplasma, is able to detect approximately 202 species including the eight specified in EP 2.6.7 for the assay validation. The performance has been validated in accordance with the mycoplasma testing requirements outlined in EP 2.6.7, JP XVIII, and USP <77>. With a limit of detection (LOD) as low as 10 CFU/mL, the kit fulfills the criteria for alternative rapid detection compared with standard 28-day culture method.
● Free of PCR aerosol contamination: Uracil-N-glycosylase (UNG) system is used to reduce the risk of false positive result.
● Quality assurance: A dual-channel detection method is applied, involving PC (positive control) and RC (recovery control), to reduce the risk of false negative result.
● High specificity: No cross-activity to cross-related bacterial species and industrial mammalian cells.
Specifications & Data
| Species | Source | GC/CFU* | Positive/Total |
|---|---|---|---|
| Mycoplasma pneumoniae | ATCC 15531 | 9.4 | 24/24 |
| Acholeplasma laidlawii | ATCC 23206 | 5.1 | 24/24 |
| Mycoplasma orale | ATCC 23714 | 6.9 | 24/24 |
| Mycoplasma hyorhinis | CVCC 361 | 9.5 | 24/24 |
| Mycoplasma fermentans | ATCC 19989 | 7.1 | 24/24 |
| Mycoplasma arginini | ATCC 23838 | 5.1 | 24/24 |
| Mycoplasma gallisepticum | ATCC 19610 | 0.7 | 24/24 |
| Mycoplasma hominis | ATCC 23114 | 7.9 | 24/24 |
Documents
MSDS_CRB101X
BROCHURE_Excellbio Assaykits_250620
MANUAL_CRB101X
Application
Gene therapy refers to a medical intervention that modifies or replaces defective genes within an individual's cells to treat or prevent diseases. ExCell Bio has developed series of products，services to support your research.
ExCell Bio has built an advanced culture media factory with large-scale, informationization and internationalization. We can provide international-leading high-performance and high-quality classical cell culture Fetal bovin serum. We can provide different
The therapeutic use of stem cells as potential therapies for a variety of diseases has been widely explored, and the number of clinical trials conducted using mesenchymal stem cells has grown exponentially in the past few years.
In the field of Immune Cell Therapy Excell Bio provides you with end-to-end solutions to help you develop therapies that can save lives. Our mission is to build Bridges to help you reach your next milestone, to help you progress, and to drive your immuno
RELATED PRODUCTS
